Real-world data from Canada showed 82% and 87% effectiveness after one dose against hospitalization or death caused by Beta/Gamma and Delta variants respectively.
Results from the Canadian Immunization Research Network (CIRN) with support from Public Health Agency of Canada and the Canadian Insti